Evidence map›Paper›PMID 21775451›Full record

ArticleJournal of virology2011

Hepatitis B virus genotype C isolates with wild-type core promoter sequence replicate less efficiently than genotype B isolates but possess higher virion secretion capacity.

Yanli Qin, Xiaoli Tang, Tamako Garcia, Munira Hussain, Jiming Zhang, Anna Lok, Jack Wands, Jisu Li, Shuping Tong

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Yanli QinThe Liver Research Center, Rhode Island Hospital, Providence, RI, USA.
Xiaoli Tang
Tamako Garcia
Munira Hussain
Jiming Zhang
Anna Lok
Jack Wands
Jisu Li
Shuping Tong
Brown University · USUniversity of Michigan–Ann Arbor · USFudan University · CNHuashan Hospital · CNRhode Island Hospital · US

Funding

Virology CoreP01AA019072 · NIAAA · BROWN UNIVERSITY · PI BECKER, SARA · 2010 to 2024
$19.7M
STUDY OF HBV AND/OR VARIANTS IN ALCOHOLICSR01AA008169 · NIAAA · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI WANDS, JACK R · 1989 to 2011
$3.9M
Molecular Target(s) for Interruption of HBV InfectionR01CA109733 · NCI · RHODE ISLAND HOSPITAL · PI LI, JISU · 2005 to 2009
$1.1M
Hepatitis B virus immune escape mutantsR21CA133976 · NCI · RHODE ISLAND HOSPITAL · PI TONG, SHUPING · 2008 to 2009
$393k
NCI NIH HHS CA109733NCI NIH HHS CA133976NCI NIH HHS R01 CA109733NCI NIH HHS R21 CA133976NIAAA NIH HHS AA08169NIAAA NIH HHS AA19072NIAAA NIH HHS P01 AA019072NIAAA NIH HHS R01 AA008169
6 · The paper itself

Abstract

Infection by hepatitis B virus (HBV) genotype C is associated with a prolonged viremic phase, delayed hepatitis B e antigen (HBeAg) seroconversion, and an increased incidence of liver cirrhosis and hepatocellular carcinoma compared with genotype B infection. Genotype C is also associated with the more frequent emergence of core promoter mutations, which increase genome replication and are independently associated with poor clinical outcomes. We amplified full-length HBV genomes from serum samples from Chinese and U. S. patients with chronic HBV infection and transfected circularized genome pools or dimeric constructs of individual clones into Huh7 cells. The two genotypes could be differentiated by Western blot analysis due to the reactivities of M and L proteins toward a monoclonal pre-S2 antibody and slightly different S-protein mobilities. Great variability in replication capacity was observed for both genotypes. The A1762T/G1764A core promoter mutations were prevalent in genotype C isolates and correlated with increased replication capacity, while the A1752G/T mutation frequently found in genotype B isolates correlated with a low replication capacity. Importantly, most genotype C isolates with wild-type core promoter sequence replicated less efficiently than the corresponding genotype B isolates due to less efficient transcription of the 3.5-kb RNA. However, genotype C isolates often displayed more efficient virion secretion. We propose that the low intracellular levels of viral DNA and core protein of wild-type genotype C delay immune clearance and trigger the subsequent emergence of A1762T/G1764A core promoter mutations to upregulate replication; efficient virion secretion compensates for the low replication capacity to ensure the establishment of persistent infection by genotype C.

Indexed as

Promoter Regions, GeneticVirus ReleaseVirus ReplicationCell LineChinaDNA Mutational AnalysisGenotypeHepatitis B, ChronicHepatitis B virusHepatocytesHumansPoint MutationUnited StatesViral LoadVirion

Identifiers

PMID21775451
PMCPMC3196399
OpenAlexW2054412906

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.